Evidence map›Paper›PMID 35716579›Full record

ArticleBiochemical pharmacology2022

Corrigendum to "Obesity III: Obesogen assays: Limitations, strengths, and new directions" [Biochem. Pharmacol. 199 (2022) 115014].

Christopher D Kassotis, Frederick S Vom Saal, Patrick J Babin, Dominique Lagadic-Gossmann, Helene Le Mentec, Bruce Blumberg, Nicole Mohajer, Antoine Legrand, Vesna Munic Kos, Corinne Martin-Chouly and 11 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Biochemical pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Christopher D KassotisInstitute of Environmental Health Sciences and Department of Pharmacology, Wayne State University, Detroit, MI 48202, United States. Electronic address: christopher.kassotis@wayne.edu.
Frederick S Vom SaalDivision of Biological Sciences, The University of Missouri, Columbia, MO 65211, United States.
Patrick J BabinDepartment of Life and Health Sciences, University of Bordeaux, INSERM, Pessac, France.
Dominique Lagadic-GossmannUniv Rennes, Inserm, EHESP, Irset (Research Institute for Environmental and Occupational Health) - UMR_S 1085, 35 000 Rennes, France.
Helene Le MentecUniv Rennes, Inserm, EHESP, Irset (Research Institute for Environmental and Occupational Health) - UMR_S 1085, 35 000 Rennes, France.
Bruce BlumbergDepartment of Developmental and Cell Biology, The University of California, Irvine, Irvine, CA 92697, United States.
Nicole MohajerDepartment of Developmental and Cell Biology, The University of California, Irvine, Irvine, CA 92697, United States.
Antoine LegrandUniv Rennes, Inserm, EHESP, Irset (Research Institute for Environmental and Occupational Health) - UMR_S 1085, 35 000 Rennes, France.
Vesna Munic KosDepartment of Physiology and Pharmacology, Karolinska Institute, Solna, Sweden.
Corinne Martin-ChoulyUniv Rennes, Inserm, EHESP, Irset (Research Institute for Environmental and Occupational Health) - UMR_S 1085, 35 000 Rennes, France.
Normand PodechardUniv Rennes, Inserm, EHESP, Irset (Research Institute for Environmental and Occupational Health) - UMR_S 1085, 35 000 Rennes, France.
Sophie LangouëtUniv Rennes, Inserm, EHESP, Irset (Research Institute for Environmental and Occupational Health) - UMR_S 1085, 35 000 Rennes, France.
Charbel ToumaUniv Rennes, Inserm, EHESP, Irset (Research Institute for Environmental and Occupational Health) - UMR_S 1085, 35 000 Rennes, France.
Robert BaroukiDepartment of Biochemistry, University of Paris, INSERM, Paris, France.
Min Ji KimSorbonne Paris Nord University, Bobigny, INSERM U1124 (T3S), Paris, France.
Karine AudouzeUniversity of Paris, T3S, INSERM U1124, Paris, France.
Mahua ChoudhuryDepartment of Pharmaceutical Sciences, Texas A & M University, College Station, TX 77843, United States.
Nitya ShreeDepartment of Pharmaceutical Sciences, Texas A & M University, College Station, TX 77843, United States.
Amita BansalCollege of Health & Medicine, Australian National University, Canberra, ACT 2611, Australia.
Sarah HowardHealthy Environment and Endocrine Disruptor Strategies, Commonweal, Bolinas, CA 92924, United States.
Jerrold J HeindelHealthy Environment and Endocrine Disruptor Strategies, Commonweal, Bolinas, CA 92924, United States.

Funding

Transgenerational obesity caused by ancestral exposure to obesogens in utero: changes in germline genomic architecture, roles of gonadal somatic cells, and metabolomic analysis of sexual dimorphismR01ES023316 · NIEHS · UNIVERSITY OF CALIFORNIA-IRVINE · PI BRUCE BLUMBERG, TOSHIHIRO SHIODA · 2013 to 2026
$8.3M
Interaction of fetal growth and bisphenol A in obesityR01ES021394 · NIEHS · UNIVERSITY OF MISSOURI-COLUMBIA · PI NAGEL, SUSAN C, VOM SAAL, FREDERICK S · 2012 to 2016
$2.5M
Interactions between prenatal obesogen exposure and Total Western diet lead to a transgenerational thrifty phenotype: functional and epigenomic analysis of effects in fat and liverR01ES031139 · NIEHS · UNIVERSITY OF CALIFORNIA-IRVINE · PI BLUMBERG, BRUCE, SHIODA, TOSHIHIRO · 2020 to 2025
$2.4M
Mechanisms of Environmental-Mixture Induced Metabolic DisruptionR00ES030405 · NIEHS · WAYNE STATE UNIVERSITY · PI KASSOTIS, CHRISTOPHER DENNIS · 2020 to 2022
$744k
NIEHS NIH HHS R00 ES030405NIEHS NIH HHS R01 ES021394NIEHS NIH HHS R01 ES023316NIEHS NIH HHS R01 ES031139
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35716579
PMCPMC9463637

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.